These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
946 related items for PubMed ID: 28146590
1. Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study. Cilveti R, Olmo M, Pérez-Jove J, Picazo JJ, Arimany JL, Mora E, Pérez-Porcuna TM, Aguilar I, Alonso A, Molina F, Del Amo M, Mendez C, HERMES Study Group. PLoS One; 2017; 12(2):e0170316. PubMed ID: 28146590 [Abstract] [Full Text] [Related]
2. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines. Leach AJ, Wigger C, Beissbarth J, Woltring D, Andrews R, Chatfield MD, Smith-Vaughan H, Morris PS. Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():224-32. PubMed ID: 27260611 [Abstract] [Full Text] [Related]
3. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme. Wouters I, Van Heirstraeten L, Desmet S, Blaizot S, Verhaegen J, Goossens H, Van Damme P, Malhotra-Kumar S, Theeten H, NPcarriage Study Group. Vaccine; 2018 Jan 02; 36(1):15-22. PubMed ID: 29180027 [Abstract] [Full Text] [Related]
5. A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation. Cohen R, Varon E, Doit C, Schlemmer C, Romain O, Thollot F, Béchet S, Bonacorsi S, Levy C. Vaccine; 2015 Sep 22; 33(39):5118-26. PubMed ID: 26271823 [Abstract] [Full Text] [Related]
6. Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial. Beissbarth J, Wilson N, Arrowsmith B, Binks MJ, Oguoma VM, Lawrence K, Llewellyn A, Mulholland EK, Santosham M, Morris PS, Smith-Vaughan HC, Cheng AC, Leach AJ. Vaccine; 2021 Apr 15; 39(16):2264-2273. PubMed ID: 33766422 [Abstract] [Full Text] [Related]
8. Pneumococcal carriage and serotype variation before and after introduction of pneumococcal conjugate vaccines in patients with acute otitis media in Switzerland. Allemann A, Frey PM, Brugger SD, Hilty M. Vaccine; 2017 Apr 04; 35(15):1946-1953. PubMed ID: 28279564 [Abstract] [Full Text] [Related]
9. Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine. Levy C, Varon E, Ouldali N, Wollner A, Thollot F, Corrard F, Werner A, Béchet S, Bonacorsi S, Cohen R. PLoS One; 2019 Apr 04; 14(2):e0211712. PubMed ID: 30707730 [Abstract] [Full Text] [Related]
11. Studying PCV impact on clinical presentation of otitis media helps to understand its pathogenesis. Ben-Shimol S, Givon-Lavi N, Leibovitz E, Greenberg D, Dagan R. Vaccine; 2019 Jan 03; 37(1):1-6. PubMed ID: 30497832 [Abstract] [Full Text] [Related]
14. Effect of Vaccination on Pneumococci Isolated from the Nasopharynx of Healthy Children and the Middle Ear of Children with Otitis Media in Iceland. Quirk SJ, Haraldsson G, Erlendsdóttir H, Hjálmarsdóttir MÁ, van Tonder AJ, Hrafnkelsson B, Sigurdsson S, Bentley SD, Haraldsson Á, Brueggemann AB, Kristinsson KG. J Clin Microbiol; 2018 Dec 03; 56(12):. PubMed ID: 30257906 [Abstract] [Full Text] [Related]
16. Pneumococcal acute otitis media in infants and children in central Romania, 2009-2011: microbiological characteristics and potential coverage by pneumococcal conjugate vaccines. Falup-Pecurariu O, Leibovitz E, Mercas A, Bleotu L, Zavarache C, Porat N, Dagan R, Greenberg D. Int J Infect Dis; 2013 Sep 03; 17(9):e702-6. PubMed ID: 23522635 [Abstract] [Full Text] [Related]
17. The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey. Soysal A, Karabağ-Yılmaz E, Kepenekli E, Karaaslan A, Cagan E, Atıcı S, Atınkanat-Gelmez G, Boran P, Merdan S, Hasdemir U, Söyletir G, Bakır M. Vaccine; 2016 Jul 19; 34(33):3894-900. PubMed ID: 27269059 [Abstract] [Full Text] [Related]
18. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era. Zuccotti G, Mameli C, Daprai L, Garlaschi ML, Dilillo D, Bedogni G, Faccini M, Gramegna M, Torresani E, PneuMi Study Group (PMSG), Ballerini E, Benincaso A, Bonvissuto M, Bricalli D, Brioschi M, Calloni CS, Camiletti MI, Colella G, De Angelis L, Decarlis S, Di Nello F, Dozzi M, Galli E, Gandini V, Giuliani MG, Laviola F, Loda B, Macedoni M, Mazzucchi E, Metta MG, Moscatiello A, Nannini P, Petruzzi M, Picicco D, Picciotti M, Pisanelli S, Porta N, Ramponi G, Redaelli F, Rubini R, Sala N, Saitta V, Scelza G, Tiso RM, Tomasetto M, Torcoletti M, Travaini M, Valentini M, Vessia C. Vaccine; 2014 Jan 23; 32(5):527-34. PubMed ID: 24342249 [Abstract] [Full Text] [Related]
20. Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in Portugal, after introduction of PCV13 in National Immunization Program: A cross-sectional study. Candeias C, Almeida ST, Paulo AC, Simões AS, Ferreira B, Cruz AR, Queirós M, Touret T, Brito-Avô A, de Lencastre H, Sá-Leão R. Vaccine; 2024 Sep 17; 42(22):126219. PubMed ID: 39146858 [Abstract] [Full Text] [Related] Page: [Next] [New Search]